Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FamiCord AGLTS:0NLV 38 Net Margin % is -5.19% as of Jun. 2026. GuruFocus rates LTS:0NLV with a GF Score™ of 38/100 and a GF Value™ of €17.48 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 672 Healthcare Providers & Services companies, FamiCord AG ranks worse than 76.34% on this metric.
Net margin is calculated as Net Income divided by its Revenue. FamiCord AG's Net Income for the
three
months ended in Jun. 2026 was €-1.13 Mil. FamiCord AG's Revenue for the
three
months ended in Jun. 2026 was €21.69 Mil. Therefore, FamiCord AG's net margin for the quarter that ended in Jun. 2026 was -5.19%.
The historical rank and industry rank for FamiCord AG's Net Margin % or its related term are showing as below:
LTS:0NLV'
s Net Margin % Range Over the Past 10 Years
Min: -39.29 Med: -2.05 Max: 7.37
Current: -8.74
LTS:0NLV's Net Margin % is ranked worse than 76.34% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: 2.83
vs LTS:0NLV: -8.74
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
FamiCord AG Net Margin % Related Terms
FamiCord AG Net Margin % Historical Data
* Premium members only.
The historical data trend for FamiCord AG's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0NLV vs HCA, THC, EHC: Net Margin % Comparison
For the Medical Care Facilities subindustry, FamiCord AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FamiCord AG Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, FamiCord AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where FamiCord AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FamiCord AG (LTS:0NLV) has a Net Margin % of -5.19% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on FamiCord AG and its competitors. According to the industry distribution chart, FamiCord AG ranks #513 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 76.3%.
Is FamiCord AG's Net Margin % too high?
FamiCord AG's current Net Margin % is -5.19%. Based on the distribution chart, FamiCord AG ranks #513 out of 672 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, FamiCord AG has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does FamiCord AG's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, FamiCord AG ranks #513 out of 672 companies for Net Margin %. This places FamiCord AG in the lower half of its industry. The industry median Net Margin % is 2.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.83, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on FamiCord AG and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FamiCord AG's current Net Margin % is -5.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FamiCord AG stock overvalued right now?
Based on GuruFocus' analysis, FamiCord AG (LTS:0NLV) is currently considered Possible Value Trap. The stock's GF Value™ is €17.48, compared to a current price of €2.78 — trading 84.1% below its estimated fair value. The current Net Margin % is -5.19%. FamiCord AG's overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For FamiCord AG (LTS:0NLV), the current Net Margin % is -5.19% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is FamiCord AG (LTS:0NLV) Overvalued in 2026?
Based on GuruFocus' analysis, FamiCord AG stock appears to be undervalued.
The current stock price of €2.78 is trading 84.1% below its estimated GF Value™ of €17.48.
GuruFocus considers FamiCord AG to be Possible Value Trap.
Key valuation signals for LTS:0NLV:
Net Margin %: -5.19%
GF Value™: €17.48 vs. price of €2.78 (84.1% below fair value)
No single metric tells the full story. See the LTS:0NLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
FamiCord AG is a German-based cord blood and tissue bank operating through subsidiaries including Vita 34 and PBKM (Polish Stem Cell Bank). The company collects, processes, cryopreserves, and stores umbilical cord blood and cord tissue stem cells for private family banking and public donation programs. It also provides logistics for sample collection and laboratory services. Beyond storage, FamiCord is expanding into cell and gene therapies and contract development and manufacturing (CDMO) services, positioning itself as a broader cell bank capable of supplying patients' own cells for current and future therapies. Its customer base includes families storing stem cells privately, public banks, hospitals, and research or clinical partners. The company operates primarily in Germany, Poland, Switzerland, and other European markets, generating revenue mainly from storage fees, processing services, and increasingly from cell therapy and CDMO activities.
38GF Score
Get the complete analysis for LTS:0NLV
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0NLV has been successfully added to your 
